Impact of Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease

IF 9.1 2区医学 Q1 PHARMACOLOGY & PHARMACY

Pharmacological research Pub Date : 2024-10-18 DOI:10.1016/j.phrs.2024.107473

Ju-Ching Yen , Jia-Yu Lai , Chi-Ya Yang, Su-Boon Yong, Chin-Yuan Yii

引用次数: 0

查看原文本刊更多论文

通讯：钠-葡萄糖共转运体 2 抑制剂（SGLT2i）和其他抗糖尿病药物在阿尔茨海默病中的应用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacological research 医学-药学

CiteScore

18.70

自引率

3.20%

发文量

491

审稿时长

8 days

期刊介绍： Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. Pharmacological research publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.